99mTechnetium-stannous oxinate as marker of liposome formulations

Nuclear Medicine and Biology

Volumn 23, Issue 7, 1996, Pages 881-887

  Alafandy, Mokarram ^a   Goffinet, Gerhard ^b   Umbrain, Vincent ^a   D'Haese, Jan ^a   Camu, Frédéric ^a   Legros, Franz J ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

(99mTc stannous oxinate liposomes; Liposome characterization; Liposome stability; Multilamellar vesicles; Small unilamellar vesicles

Indexed keywords

LIPOSOME; TECHNETIUM 99M; TIN DERIVATIVE; TIN DIOXINATE; UNCLASSIFIED DRUG; CHOLESTEROL; DIOXANE DERIVATIVE; DRUG CARRIER; LYSOPHOSPHATIDYLCHOLINE; ORGANOTIN COMPOUND; PHOSPHATIDYLCHOLINE; TECHNETIUM COMPLEX; TECHNETIUM TC 99M STANNOUS OXINATE; TIN(II) DIOXINATE;

ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG FORMULATION; HUMAN; HUMAN TISSUE; PHARMACOKINETICS; SCINTISCANNING; CHEMISTRY; COLLOID; ELECTRON MICROSCOPY; FREEZE ETCHING; REPRODUCIBILITY; TIME;

CHOLESTEROL; COLLOIDS; DIOXANES; DRUG CARRIERS; FREEZE ETCHING; HUMANS; LIPOSOMES; LYSOPHOSPHATIDYLCHOLINES; MICROSCOPY, ELECTRON; ORGANOTECHNETIUM COMPOUNDS; ORGANOTIN COMPOUNDS; PHOSPHATIDYLCHOLINES; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0030256441     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00118-7     Document Type: Article

References (33)

1. 99mTc-labelled liposomes. J. Nucl. Biol. Med. 20, 165-167.
2. 2. Anghileri L. J., Firusian N. and Heidbreder M. (1977) A radiocompound with possibilities for lymphoscintigraphic studies. Eur. J. Nucl. Med. 2, 109-111.
3. 3. Asakawa T. and Matsushita S. (1980) Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 15, 137-140.
4. 4. Barenholz Y. and Amselem S. (1993) Quality control assays in the development and clinical use of liposome-based formulations. In: Liposome Technology: Vol. I (Edited by Gregoriadis G.), pp. 527-616. CRC Press, Boca Raton, FL.
5. 5. Barratt G. M., Tuzel N. S. and Ryman B. E. (1984) The labeling of liposomal membranes with radioactive technetium. In: Liposome Technology: Vol. I. (Edited by Gregoriadis G.), pp. 93-106. CRC Press, Boca Raton, FL.
6. 6. Betageri G. V., Jenkins S. A. and Parsons D. L. (1993) Liposome Drug Delivery Systems, pp. 29-45. Technomic Publishing, Lancaster, PA.
7. 7. Blakemore W. F., Eames R. A., Smith K. and McDonald W. I. (1977) Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J. Neuroi. Sci. 33, 31-43.
8. 8. Boogaerts J. G., Lafont N. D., Declercq A. G., Luo H. C., Gravet E. T., Bianchi J. A. and Legros F. J. (1994) Epidural administration of liposome-associated bupivacaine for the management of postoperative pain: A first study. J. Clin. Anesth. 6, 315-320.
9. 9. Boogaerts J. G., Lafont N. D., Donnay M., Luo H. and Legros F. J. (1995) Motor blockade and absence of local nerve toxicity induced by liposomal bupivacaine injected into the brachial plexus of rabbits. Acta Anaesth. Belg. 46, 19-24.
10. 10. Caride V. J. (1990) Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging. Nucl. Med. Biol. 17, 35-39.
11. 11. Espinola L. G., Beaucaire J., Gottschalk A. and Caride V. J. (1979) Radiolabeled liposomes as metabolic and scanning tracers in mice: II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles. J. Nucl. Med. 20, 434-440.
12. 12. Goins B., Klipper R., Rudolph A. S., Cliff R. O., Blumhardt R. and Phillips W. T. (1993) Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J. Nucl. Med. 34, 2160-2168.
13. 13. Guidelines on the validation of the Limulus amoebocyte lysate test as an end-product endotoxin test for human and animal parental drugs, biological products, and medical devices. (1987) Washington, DC: U.S. Food and Drug Administration.
14. 14. Hauser H. (1993) Phospholipid vesicles. In: Phospholipids Handbook (Edited by Cevc G.), pp. 527-616. Marcel Dekker, New York.
15. 15. Hnatowich D. J. and Clancy B. (1980) Investigations of a new, highly negative liposome with improved biodistribution for imaging. J. Nucl. Med. 21, 662-669.
16. 16. Hnatowich D. J., Friedman B., Clancy B. and Novak M. (1981) Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation. J. Nucl. Med. 22, 810-814.
17. 17. Hwang K. J. (1978) Modes of interaction of (In3+)-8-hydroxyquinoline with membrane bilayers. J. Nucl. Med. 19, 1162-1170.
18. 18. Hwang K. J. and Mauk M. R. (1977) Fate of lipid vesicles in vivo: A gamma-ray perturbed angular correlation study. Proc, Natl. Acad. Sci. USA 74, 4991-4995.
19. 19. Lafont N. D., Legros F. J. and Boogaerts J. G. (1994) Use of liposome-associated bupivacaine for the management of a chronic pain syndrome. Anesth. Analg. 79, 818.
20. 20. Legros F. J., Alafandy M., Delcourt E., Lafont N. and Boogaerts J. (1993) Fate of liposomes administered intravenously. Anesthesiology 79, A443.
21. 21. Legros F., Luo H., Bourgeois P., Lafont N. and Boogaerts J. (1990) Influence of different liposomal formulations on the pharmacokinetics of encapsulated bupivacaine. Anesthesiology 73, A851.
22. 22. Lentner C. (1981) Geigy Scientific Tables (pp. 174-175). Medical Education Division, Ciba-Geigy Corp., West Caldwell, NJ.
23. 23. Lichtenberg D. and Barenholz Y. (1988) Liposomes: Preparation, characterization, and preservation. Meth. Biochem. Anal. 33, 338-459.
24. 24. Lin M. S. and Winchel S. (1971) A "kit" method for the preparation of a technetium-tin(II) colloid and a study of its properties. J. Nucl. Med. 13, 58-65.
25. 25. New R. R. C. (1990) Characterization of liposomes. In: Liposomes: A Practical Approach (Edited by New R. R. C.), pp. 105-162. IRL Press, Oxford.
26. 26. Ogihara J., Kojima S. and Jay M. (1986) Differential uptake of Ga-67-labeled liposomes between tumors and inflammatory lesions in rats. J. Nucl. Med. 27, 1300-1307.
27. 27. Pettit W. A., DeLand F. H., Pepper G. H. and Blanton L. (1978) Characterization of tin-technetium colloid in technetium-labeled albumin preparations. J. Nucl. Med. 19, 387-392.
28. 28. Phillips W. T., Rudolph A. S., Goins B., Timmons J. H., Klipper R. and Blumhardt R. (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl. Med. Biol. 19, 509-517.
29. 29. Presant C. A., Proffitt R. T., Williams L. E., Winsor D., Werner J. L., Kennedy P., Wiseman C., Gala K., McKenna R. J., Smith J. D., Bouzaglou S. A., Callahan R. A., Baldeschwieler J. and Crosseley R. J. (1989) Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer 46, 951.
30. 30. Profitt R. T., Williams L. E., Presant C. A., Tin G. W., Uliana J. A., Gamble R. C. and Baldeschwieler J. D. (1983) Tumor-imaging potential of liposomes loaded with In-111-NTA: Biodistribution in mice. J. Nucl. Med. 24, 45-51.
31. 31. Smith K. and McDonald W. I. (1980) Spontaneous and mechanically evoked activity due to central demyelinating lesion. Nature 286, 154-155.
32. 32. Stewart J. C. M. (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104, 10-14.
33. 33. Umbrain V., Alafandy M., Bourgeois P., D'Haese J., Boogaets J. G., Goffinet G., Camu F. and Legros F. J. (1995) Biodistribution of liposomes after extradural administration in rodents. Br. J. Anaesth. 75, 311-319.